6505--Omeprazole Dr Capsules- NAC Repack
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79725R0002
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is seeking to establish a supply source for Omeprazole DR Capsules through a solicitation targeting pharmaceutical manufacturers. The procurement is divided into two distinct groups: Group 1 for Other Government Agencies to acquire through the Pharmaceutical Prime Vendor (PPV) program, and Group 2 for VA ordering activities through the Repackaging program. Offerors must propose prices for a base year and four consecutive one-year option periods, with the requirement to submit prices for all line items within each group to be considered. The solicitation mandates that pricing shall not exceed two decimal places and must include a 0.5% Cost Recovery Fee. The final deadline for proposal submissions is December 27, 2024, at 2:30 PM CST, with the anticipated contract start date of November 14, 2024.
The solicitation is structured to support multiple packaging requirements, including bottled capsules in 20mg and 40mg strengths with various package sizes ranging from 90-count unit-of-use packages to 1000-count bottles, as well as bulk capsule quantities. Annual quantities are substantial, with Group 1 requiring between 238 and 36,848 bottles across different specifications, and Group 2 demanding 272,800,000 capsules for 20mg strength and 61,000,000 capsules for 40mg strength. A unique repackaging fee of $0.0314 per bottle will be added to evaluation prices for bottles under 10,000-count, and bulk products must maintain at least 18 months of shelf life at the time of shipment. While the original solicitation indicated a small business set-aside, the current amendment does not specify this restriction. The procurement will be distributed through the VA Pharmaceutical Prime Vendor Program and the VA Pharmaceutical Repackaging Program, with the potential for either a single contract covering both groups or separate contracts for each group.
Notice text
3 versions
Update #3 · Latest ·
Page 5 of 89
Continuation of SF-1449, Block 3:
The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period.
Contract Award/Effective Date: ___________________
Implementation Period: __________________________
Ordering Period (Base Year): _____________________
Offerors shall not enter information into the above fields.
Continuation of SF-1449, Blocks 19 through 24:
Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b), and Group 2 (line items 1 and 2) represent two separate requirements for purposes of FAR Clause 52.217-9, Option to Extend the Terms of the Contract and Clause 52.233-2 Service of Protest . For the purpose of determining the lowest-priced, technically acceptable offer(s) the Government will evaluate each group separately. To be considered for award for Group 1, offerors are required to submit prices for Group 1 line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b for the base and all four option years. To be considered for award for Group 2, offerors are required to submit prices for Group 2 line item 1 and 2 for the base and all four option years. Offered prices shall not exceed two decimal places.
Award will be made in the aggregate for Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b); and Group 2, (line items 1 and 2). The Government may award two separate contracts for Group 1 and Group 2, or one contract for both groups.
Line items 1 and 4 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application
Group 1 (OGAs)
Line Item 1 - Omeprazole DR 20mg Capsules, 90 Capsules per Bottle (Unit of Use)
NDC # __________________ ANDA#______________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
238
Bottles
Option Year One
238
Bottles
Option Year Two
238
Bottles
Option Year Three
238
Bottles
Option Year Four
238
Bottles
Line Item 2 -Omeprazole DR 20mg Capsules, 100 Capsules per Bottle
NDC # __________________ ANDA#__________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
1,633
Bottles
Option Year One
1,633
Bottles
Option Year Two
1,633
Bottles
Option Year Three
1,633
Bottles
Option Year Four
1,633
Bottles
3a OR 3b
Line Item 3a - Omeprazole DR 20mg Capsules, 500 Capsules per Bottle
NDC # __________________ ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
36,848
Bottles
Option Year One
36,848
Bottles
Option Year Two
36,848
Bottles
Option Year Three
36,848
Bottles
Option Year Four
36,848
Bottles
OR
Line Item 3b - Omeprazole DR 20mg Capsules, 1000 Capsules per Bottle
NDC # __________________ ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
18,424
Bottles
Option Year One
18,424
Bottles
Option Year Two
18,424
Bottles
Option Year Three
18,424
Bottles
Option Year Four
18,424
Bottles
Line Item 4 - Omeprazole DR 40mg Capsules, 90 Capsules per Bottle (Unit of Use)
NDC # _______________________ ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
562
Bottles
Option Year One
562
Bottles
Option Year Two
562
Bottles
Option Year Three
562
Bottles
Option Year Four
562
Bottles
Line Item 5 -Omeprazole DR 40mg Capsules, 100 Capsules per Bottle
NDC # __________________
ANDA#___________________________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
592
Bottles
Option Year One
592
Bottles
Option Year Two
592
Bottles
Option Year Three
592
Bottles
Option Year Four
592
Bottles
6a OR 6b
Line Item 6a - Omeprazole DR 40mg Capsules, 500 Capsules per Bottle
NDC # __________________
ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
11,728
Bottles
Option Year One
11,728
Bottles
Option Year Two
11,728
Bottles
Option Year Three
11,728
Bottles
Option Year Four
11,728
Bottles
OR
Line Item 6b - Omeprazole DR 40mg Capsules, 1000 Capsules per Bottle
NDC # __________________
ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
5,864
Bottles
Option Year One
5,864
Bottles
Option Year Two
5,864
Bottles
Option Year Three
5,864
Bottles
Option Year Four
5,864
Bottles
Group 2 (VA)
Line Item 1 - Omeprazole DR 20mg Capsules, Bulk
NDC # __________________ ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Drum or PKG Size
Base Year
272,800,000
Capsules
Option Year One
272,800,000
Capsules
Option Year Two
272,800,000
Capsules
Option Year Three
272,800,000
Capsules
Option Year Four
272,800,000
Capsules
Line Item 2 - Omeprazole DR 40mg Capsules, Bulk
NDC # __________________ ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Drum or PKG Size
Base Year
61,000,000
Capsules
Option Year One
61,000,000
Capsules
Option Year Two
61,000,000
Capsules
Option Year Three
61,000,000
Capsules
Option Year Four
61,000,000
Capsules
** The minimum package size for Group 2 (bulk) is 1,000 tablet count. The 1,000 tablet count will be accepted for Group 2 but a larger package size such as 10,000 Tablet drums or larger are desired for the bulk (See Section 1.5 in the Scope of Contract section of this solicitation)
For each of the drug strengths listed in Group 2. For the base year only or earlier, if an offeror is not able to provide the drug in larger quantities i.e. 10,000 Tablet drums or larger, VA will accept 1,000 count bottles. When VA exercises the first option year, the successful offeror awarded the contract under this solicitation must provide in quantities of at 10,000 count drums for each of the strengths.
For the purpose of evaluating offers, $0.0314 (VA awarded repackaging fee) per bottle will be added if the bottle is under 10,000 tablet count required to meet the estimated annual requirements. For example, if 1000 count bottles were proposed for Group 2, item 2 (which has estimated annual requirements of 51,000,000 capsules), $.0314 would be multiplied by 51,000. This figure would be added to the total annual price for price evaluation purposes. The $0.0314 per bottle represents the repackaging cost to the Government during the base year of contract performance for a contract awarded under this solicitation and will be included in the calculation of the lowest total aggregate price for evaluation of award.
** The estimated annual usage cited above is the Government s total estimated usage for the strength and bottle size/capsule count listed. There is no expressed or implied guarantee that the estimated quantities will be purchased under this contract. Actual quantities purchased may exceed or be less than those represented.
***Bulk Product (GROUP 2) must have at least 18 months of dating prior to product expiration on the date of shipment from the contract holder to the Pharmaceutical Repackager.
****Price Evaluation note:
GROUP 1 will be evaluated based on unit prices (per bottle price)
GROUP 2 will be evaluated based on unit prices (per capsule price)
+ 0.0314 if the tablet count is 1,000 as described above.
Update #2 ·
See Omeprazole National Procurement issued 11/14/2024
Update #1 ·
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0002 0002.docx | DOCX document | |
| Amend 02_page 2_OMP.docx | DOCX document | |
| 36E79725R0002 0001.docx | DOCX document | |
| 36E79725R0002.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Omeprazole Dr Capsules- NAC Repack | Award Notice | |
| This notice | Solicitation | |
| 6505--Omeprazole Dr Capsules- NAC Repack | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity